Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TAP2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | TXNRD3NB | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | CEP55 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | PURG | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | EIF3A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | AC240274.1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ASRGL1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | WTAP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | PLCB1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | NAALADL1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |